PROGEN — Prostatype Genomics AB Share News
0.000.00%
Last trade - 00:00- SEK52.52m
- SEK52.13m
- SEK0.59m
Brief: Prostatype Genomics Establishes Subsidiary In The U.S.
Brief: Prostatype Genomics Q4 EBITDA Loss Widens To SEK 5.7 Mln
Brief: Prostatype Announces Outcome Of Exercise Of Warrants Of Series TO 1
Brief: Prostatype Genomics Q3 EBITDA Stable At SEK 3.6 Mln
Brief: Board Of Directors And Management Of Prostatype Genomics AB Enter Into Agreements Regarding Lock Up
Brief: Prostatype Genomics Enters The Italian Market
Brief: Prostatype Genomics Says Co Enters German Market
Brief: Prostatype Genomics Enters German Market
Brief: Prostatype Carries Out Directed New Issue Of SEK 24.7 Mln
Brief: Prostatype Genomics AB Says Has Signed A Cooperation Agreement With Proteomedix AG
Brief: Prostatype Genomics AB Says Intends To Carry Out A Directed Share Issue Of Approximately Sek 24 Mln
Brief: Prostatype Study Results To Be Presented At World's Top Urology Meeting
Brief: Prostatype Genomics Q2 EBITDA Loss At SEK 2.4 Mln
Brief: Prostatype Signs Deal With Cambridge Clinical Laboratories
Brief: Prostatype Genomics Signs Multiyear Agreement With Minerva Biolabs
Brief: Prostatype Genomics Q1 EBITDA Loss SEK 3.4 Mln
Brief: Prostatype Genomics Announces Strong Results For Prostatype In First Step Validation Study Of Asian Population
Brief: Prostatype Genomics Q6 EBITDA Loss Widens To SEK 4.7 Million
Brief: Prostatype Genomics Gets Patent For Prostatype In Canada